{
    "nctId": "NCT03598660",
    "briefTitle": "Role of Sorcin and Annexin A3 in Breast Cancer Patients",
    "officialTitle": "Role of Sorcin and Annexin A3 in Breast Cancer Patients",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 80,
    "primaryOutcomeMeasure": "Role of SORCIN in patients with breast cancer",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* breast cancer patients before surgery who are admitted to the South Egypt Cancer Institute, Surgery Department, Assiut University\n\nExclusion Criteria:\n\n* \u2022 Patients with malignancies elsewhere in the body.\n\n  * Patients with chronic cardiac diseases.\n  * Getting neoadjuvant chemotherapy.\n  * Renal disease.\n  * Neurodegenerative disease.",
    "sex": "FEMALE",
    "minimumAge": "20 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}